Claro Advisors LLC Eli Lilly & CO Transaction History

Claro Advisors LLC

$569 Million
Q2 2025

A detailed history of Claro Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Claro Advisors LLC holds 2,878 shares of LLY stock, worth $2.43 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

2,878

Previous 3,731 22.86%

Holding current value

$2.43 Million

Previous $3.08 Million 27.2%

% of portfolio

0.39%

Previous 0.46%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$713.71 - $898.95 $608,794 - $766,804	-853 Reduced 22.86%	2,878 $2.24 Million
Q1 2025 May 12, 2025	BUY	$725.72 - $929.72 $146,595 - $187,803	202 Added 5.72%	3,731 $3.08 Million
Q4 2024 Jan 13, 2025	SELL	$727.2 - $932.06 $498,132 - $638,461	-685 Reduced 16.26%	3,529 $2.72 Million
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $264,071 - $328,326	-342 Reduced 7.51%	4,214 $3.73 Million
Q3 2024 Oct 17, 2024	BUY	$772.14 - $960.02 $560,573 - $696,974	726 Added 18.96%	4,556 $4.04 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $156,571 - $196,352	216 Added 5.98%	3,830 $3.47 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $1.35 Million - $1.8 Million	2,272 Added 169.3%	3,614 $2.81 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $18,906 - $22,288	-36 Reduced 2.61%	1,342 $782,000
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $17,822 - $24,571	-41 Reduced 2.89%	1,378 $740,000
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $24,551 - $32,828	70 Added 5.19%	1,419 $665,000
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $12,114 - $14,227	39 Added 2.98%	1,349 $463,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $60,772 - $70,812	189 Added 16.86%	1,310 $479,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $42,366 - $49,745	152 Added 15.69%	1,121 $363,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3,822 - $4,743	17 Added 1.79%	969 $268,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $3,988 - $4,908	18 Added 1.93%	952 $220,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $168,633 - $218,126	934 New	934 $214,000
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $81,701 - $96,168	-734 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $77,730 - $87,081	734 New	734 $79,000

Others Institutions Holding LLY

# of Institutions

4,451

Shares Held

781M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Eli Lilly & CO Transaction History